Hospi Corporation

Hospi Corporation is a private, commercial-stage medical device company focused on improving quality of life in post-acute care. The company has successfully brought its first product, the Macy Catheter®, to market with FDA 510(k) clearance, targeting unmet needs in symptom management for patients with compromised oral routes. Founded by a veteran hospice nurse and an experienced medtech executive, Hospi leverages deep clinical insight to develop simple, high-impact devices that address caregiver burden and cost. Its initial commercial focus is on the hospice, palliative care, and home health markets in the United States.

Nurse-informed design of practical, patient-centric medical devices for drug delivery and caregiver support in post-acute care.

Competition is likely fragmented, consisting of traditional methods (suppositories, injections, IV lines) and possibly other rectal catheters. Hospi's primary competition is the status quo of less comfortable or more invasive alternatives. Its key differentiators are the nurse-designed focus on patient comfort/dignity, the soft silicone material of the Macy Catheter, and a value proposition explicitly targeting caregiver ease and system cost reduction.